Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy

NCT02288832 is registered in ClinicalTrials.gov with Assistance Publique Hopitaux De Marseille as lead sponsor.

NCT NCT02288832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by "Point-of-care" During Pregnancy
Lead sponsor
Assistance Publique Hopitaux De Marseille
Phase
Phase 2/3
Overall status
Completed
Start date
March 6, 2015
Completion date
October 21, 2022
Enrollment
6,800 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

low risk of preterm delivery